Amicus Therapeutics (FOLD) Leases (2019 - 2025)
Historic Leases for Amicus Therapeutics (FOLD) over the last 7 years, with Q3 2025 value amounting to $21.5 million.
- Amicus Therapeutics' Leases fell 689.16% to $21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.5 million, marking a year-over-year decrease of 689.16%. This contributed to the annual value of $22.3 million for FY2024, which is 1533.14% down from last year.
- Amicus Therapeutics' Leases amounted to $21.5 million in Q3 2025, which was down 689.16% from $22.0 million recorded in Q2 2025.
- In the past 5 years, Amicus Therapeutics' Leases ranged from a high of $30.4 million in Q2 2022 and a low of $20.6 million during Q4 2021
- Over the past 5 years, Amicus Therapeutics' median Leases value was $23.0 million (recorded in 2024), while the average stood at $24.9 million.
- Per our database at Business Quant, Amicus Therapeutics' Leases plummeted by 3119.29% in 2021 and then soared by 4346.64% in 2022.
- Amicus Therapeutics' Leases (Quarter) stood at $20.6 million in 2021, then skyrocketed by 43.47% to $29.5 million in 2022, then dropped by 10.91% to $26.3 million in 2023, then decreased by 15.33% to $22.3 million in 2024, then dropped by 3.27% to $21.5 million in 2025.
- Its Leases was $21.5 million in Q3 2025, compared to $22.0 million in Q2 2025 and $22.1 million in Q1 2025.